William M. Tahaney

Molecularly targeted therapies for p53-mutant cancers

P. Brown, A. Mazumdar, Dekuang Zhao, 2017, Cellular and Molecular Life Sciences.

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1

G. Mills, P. Brown, A. Mazumdar, 2020, npj Breast Cancer.

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1

G. Mills, P. Brown, A. Mazumdar, 2020, npj Breast Cancer.

Molecularly targeted therapies for p53-mutant cancers

P. Brown, A. Mazumdar, Dekuang Zhao, 2017, Cellular and Molecular Life Sciences.

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression

G. Mills, P. Brown, Yun Zhang, 2019, npj Breast Cancer.

SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis

P. Brown, Yun Zhang, A. Mazumdar, 2020, Molecular Cancer Research.

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression

G. Mills, P. Brown, Yun Zhang, 2019, npj Breast Cancer.

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

P. Brown, Yun Zhang, Altaf Mohammed, 2022, Cancer prevention research.

380 The kinesin-like protein Kif11 is essential for the survival of TP53 mutant triple-negative breast cancer cells

P. Brown, A. Mazumdar, William M. Tahaney, 2023, Journal of Clinical and Translational Science.